Toll Free: 1-888-928-9744

Global Conjugate Vaccines Market Research Report 2021

Published: Aug, 2016 | Pages: 102 | Publisher: QYResearch
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Conjugate animal vaccine is a sort of subdivision vaccine wherein antigens are combined with transporter proteins. The vaccines presently in usage for kids in contradiction of pneumococcal bacteriological contaminations are prepared with this method. Conjugate vaccines are similarly utilized in contradiction of Hemophilic influenza type B (Hib). PedvaxHIB [Hemophilic b Conjugate Vaccine (Meningococcal Protein Conjugate)] and COMVAX [Hemophilic b Conjugate (Meningococcal Protein Conjugate)] are more or less sorts of conjugate vaccines.

The important issues that are motivating the progress of the international market of Conjugate Vaccines comprise growing usage of conjugate vaccines for adults, increasing figure of governing appreciations for conjugate vaccines, growing occurrence of illnesses, and technical improvements. Yet, small availability towards vaccines in distant regions and difficult manufacture process of conjugate vaccine are likely to limit the progress of this market. Developing markets like China and India present a range of openings for this market.

The area of North America controls the conjugate vaccines market. The U.S. is responsible for a main market stake. Yet, the Asia is composed to develop at the utmost CAGR in the prediction period due to the governmental resourcefulness, increasing concentration of main companies on the Indian market, and growing vaccination inventiveness by establishments like World Health Organization and GAVI in these areas.

The area of Europe is the rapidly developing market due to a much systematized livestock section. This progress is credited to its systematized livestock farmhouses and the enormous call for livestock products like food [Eggs, Milk, Meat, and its sub products] and non-food substances from the European populace. The call for livestock merchandises is great in European nations. The international market of the Conjugate Vaccines is largely categorized into know-how, sort, sickness sign, final consumers, and areas.

As per the source of know-how, the vaccines market is segmented into conjugate vaccines, inactivated and subunit vaccines live attenuated vaccines, toxoid vaccines, and recombinant vaccines. The conjugate vaccines section was projected to describe the biggest stake of the international market in 2016. Growing government backing for vaccine improvement and increasing company funds will motivate the development of this market section.

On the basis of sort of vaccines, the vaccines market is sectioned into monovalent vaccines and multivalent vaccines. The monovalent vaccines section is projected to justify for the biggest stake of this market. The big stake of the market is credited to growing occurrence of sicknesses and growing government and non-government inventiveness for vaccine R&D undertakings.

As per the sign of sickness, the vaccines market sections are influenza, tetanus, diphtheria and pertussis (DTP), pneumococcal disease, varicella, hepatitis, meningococcal disease, rotavirus, measles, mumps and rubella (MMR), polio, human papilloma virus (HPV) infection, and others. The pneumococcal sickness section was projected to describe the biggest stake of the international market in 2016. High occurrence of pneumococcal contaminations and the necessity for injections to avoid the sickness strengthens the progress of market of this section.

Final consumers, comprised in the vaccines market are pediatrics and adults. The pediatrics section was expected to justify for the biggest stake of the international market in 2016. Increasing amount of alertness series to encourage vaccination has caused in the growing usage of vaccines for pediatrics. On the basis of geography, the vaccines market is ruled by North America, tracked by Europe, Asia, and the Rest of the World [RoW]. 

Progress in the section of North America is mainly pushed by government inventiveness for vaccination in contradiction of sicknesses like influenza and HPV in the North American nations. Some important companies that are working in the field of Conjugate Vaccines at the international level include Novartis AG, Neuron Biotech, Serum Institute of India, Pfizer, Inc., Sanofi Pasteur, Bharat Biotech, Biological E, GlaxoSmithKline, plc., Merck and Company, and CSL Limited.
 Table of Contents

Global Conjugate Vaccines Market Research Report 2021

1 Conjugate Vaccines Overview
    1.1 Product Overview and Scope of Conjugate Vaccines
    1.2 Conjugate Vaccines Segment by Types
        1.2.1 Global Sales Market Share of Conjugate Vaccines by Type in 2015
        1.2.2 Pneumococcal
        1.2.3 Influenza
        1.2.4 HPV
        1.2.5 Hepatitis
        1.2.6 Rotavirus
        1.2.7 DTP
        1.2.8 Polio
        1.2.9 MMR
    1.3 Conjugate Vaccines Segment by Applications
        1.3.1 Pediatric
        1.3.2 Adult
        1.3.3 Application 3
    1.4 Conjugate Vaccines Market by Regions
        1.4.1 North America Status and Prospect (2011-2021)
        1.4.2 China Status and Prospect (2011-2021)
        1.4.3 Europe Status and Prospect (2011-2021)
        1.4.4 Japan Status and Prospect (2011-2021)
        1.4.5 India Status and Prospect (2011-2021)
        1.4.6 Southeast Asia Status and Prospect (2011-2021)
    1.5 Global Market Size (Value and Volume) of Conjugate Vaccines (2011-2021)
        1.5.1 Global Conjugate Vaccines Sales and Revenue (2011-2021)
        1.5.2 Global Conjugate Vaccines Sales and Growth Rate (2011-2021)
        1.5.3 Global Conjugate Vaccines Revenue and Growth Rate (2011-2021)

2 Global Conjugate Vaccines Market Competition by Manufacturers
    2.1 Global Conjugate Vaccines Sales and Share by Manufacturers (2015 and 2016)
    2.2 Global Conjugate Vaccines Revenue and Share by Manufacturers (2015 and 2016)
    2.3 Manufacturers Conjugate Vaccines Manufacturing Base Distribution and Product Type
    2.4 Competitive Situation and Trends
        2.4.1 Expansions
        2.4.2 New Product Launches
        2.4.3 Acquisitions
        2.4.4 Other Developments

3 Global Conjugate Vaccines Analysis by Region
    3.1 Global Conjugate Vaccines Sales, Revenue and Market Share by Region (2011-2021)
        3.1.1 Global Conjugate Vaccines Sales Market Share by Region (2011-2021)
        3.1.2 Global Conjugate Vaccines Revenue Market Share by Region (2011-2021)
    3.2 North America
        3.2.1 North America Conjugate Vaccines Sales, Revenue and Price (2011-2021)
        3.2.2 North America Conjugate Vaccines Sales, Revenue and Growth Rate (2011-2021)
    3.3 Europe
        3.3.1 Europe Conjugate Vaccines Sales, Revenue and Price (2011-2021)
        3.3.2 Europe Conjugate Vaccines Sales, Revenue and Growth Rate (2011-2021)
    3.4 China
        3.4.1 China Conjugate Vaccines Sales, Revenue and Price (2011-2021)
        3.4.2 China Conjugate Vaccines Sales, Revenue and Growth Rate (2011-2021)
    3.5 Japan
        3.5.1 Japan Conjugate Vaccines Sales, Revenue and Price (2011-2021)
        3.5.2 Japan Conjugate Vaccines Sales, Revenue and Growth Rate (2011-2021)
    3.6 India
        3.6.1 India Conjugate Vaccines Sales, Revenue and Price (2011-2021)
        3.6.2 India Conjugate Vaccines Sales, Revenue and Growth Rate (2011-2021)
    3.7 Southeast Asia
        3.7.1 Southeast Asia Conjugate Vaccines Sales, Revenue and Price (2011-2021)
        3.7.2 Southeast Asia Conjugate Vaccines Sales, Revenue and Growth Rate (2011-2021)

4 Global Conjugate Vaccines Analysis by Type
    4.1 Global Conjugate Vaccines Sales, Revenue, Market Share and Growth Rate by Type (2011-2021)
        4.1.1 Global Conjugate Vaccines Sales and Market Share by Type (2011-2021)
        4.1.2 Global Conjugate Vaccines Revenue, Market Share and Growth Rate by Type (2011-2021)
    4.2 Pneumococcal Sales, Revenue, Price and Growth (2011-2021)
    4.3 Influenza Sales, Revenue, Price and Growth (2011-2021)
    4.4 HPV Sales, Revenue, Price and Growth (2011-2021)
    4.5 Hepatitis Sales, Revenue, Price and Growth (2011-2021)
    4.6 Rotavirus Sales, Revenue, Price and Growth (2011-2021)
    4.7 DTP Sales, Revenue, Price and Growth (2011-2021)
    4.8 Polio Sales, Revenue, Price and Growth (2011-2021)
    4.9 MMR Sales, Revenue, Price and Growth (2011-2021)

5 Global Conjugate Vaccines Market Analysis by Application
    5.1 Global Conjugate Vaccines Sales and Market Share by Application (2011-2021)
    5.2 Major Regions Conjugate Vaccines Sales by Application in 2015 and 2016
        5.2.1 North America Conjugate Vaccines Sales by Application
        5.2.2 Europe Conjugate Vaccines Sales by Application
        5.2.3 China Conjugate Vaccines Sales by Application
        5.2.4 Japan Conjugate Vaccines Sales by Application
        5.2.5 India Conjugate Vaccines Sales by Application
        5.2.6 Southeast Asia Conjugate Vaccines Sales by Application

6 Global Conjugate Vaccines Manufacturers Analysis
    6.1 Astellas Pharma Inc
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Conjugate Vaccines Product Overview
            6.1.2.1 Pneumococcal
            6.1.2.2 Influenza
            6.1.2.3 HPV
        6.1.3 Conjugate Vaccines Sales, Revenue, Price of Astellas Pharma Inc (2015 and 2016)
    6.2 CSL Limited
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Conjugate Vaccines Product Overview
            6.2.2.1 Pneumococcal
            6.2.2.2 Influenza
            6.2.2.3 HPV
        6.2.3 Conjugate Vaccines Sales, Revenue, Price of CSL Limited (2015 and 2016)
    6.3 Emergent BioSolutions, Inc
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Conjugate Vaccines Product Overview
            6.3.2.1 Pneumococcal
            6.3.2.2 Influenza
            6.3.2.3 HPV
        6.3.3 Conjugate Vaccines Sales, Revenue, Price of Emergent BioSolutions, Inc (2015 and 2016)
    6.4 GlaxoSmithKline
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Conjugate Vaccines Product Overview
            6.4.2.1 Pneumococcal
            6.4.2.2 Influenza
        6.4.3 Conjugate Vaccines Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
    6.5 Johnson & Johnson
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Conjugate Vaccines Product Overview
            6.5.2.1 Pneumococcal
            6.5.2.2 Influenza
        6.5.3 Conjugate Vaccines Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
    6.6 MedImmune, LLC
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Conjugate Vaccines Product Overview
            6.6.2.1 Pneumococcal
            6.6.2.2 Influenza
        6.6.3 Conjugate Vaccines Sales, Revenue, Price of MedImmune, LLC (2015 and 2016)
    6.7 Merck & Co
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Conjugate Vaccines Product Overview
            6.7.2.1 Pneumococcal
            6.7.2.2 Influenza
        6.7.3 Conjugate Vaccines Sales, Revenue, Price of Merck & Co (2015 and 2016)
    6.8 Pfizer
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Conjugate Vaccines Product Overview
            6.8.2.1 Pneumococcal
            6.8.2.2 Influenza
        6.8.3 Conjugate Vaccines Sales, Revenue, Price of Pfizer (2015 and 2016)
    6.9 Sanofi Pasteur
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Conjugate Vaccines Product Overview
            6.9.2.1 Pneumococcal
            6.9.2.2 Influenza
        6.9.3 Conjugate Vaccines Sales, Revenue, Price of Sanofi Pasteur (2015 and 2016)
    6.10 Serum Institute
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Conjugate Vaccines Product Overview
            6.10.2.1 Pneumococcal
            6.10.2.2 Influenza
        6.10.3 Conjugate Vaccines Sales, Revenue, Price of Serum Institute (2015 and 2016)
    6.11 India Pvt. Ltd. (India)

7 Industry Policy Analysis

8 Research Findings and Conclusion
List of Tables and Figures

Figure Picture of Conjugate Vaccines
Figure Global Sales Market Share of Conjugate Vaccines by Type in 2015
Table Conjugate Vaccines Product Type of by Manufacturers
Table Conjugate Vaccines Sales Market Share by Application in 2015 and 2016
Figure North America Conjugate Vaccines Revenue and Growth Rate (2011-2021)
Figure China Conjugate Vaccines Revenue and Growth Rate (2011-2021)
Figure Europe Conjugate Vaccines Revenue and Growth Rate (2011-2021)
Figure Japan Conjugate Vaccines Revenue and Growth Rate (2011-2021)
Figure India Conjugate Vaccines Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Conjugate Vaccines Revenue and Growth Rate (2011-2021)
Table Global Conjugate Vaccines Sales and Revenue (2011-2021)
Figure Global Conjugate Vaccines Sales and Growth Rate (2011-2021)
Figure Global Conjugate Vaccines Revenue and Growth Rate (2011-2021)
Table Global Conjugate Vaccines Sales of Key Manufacturers (2015 and 2016)
Table Global Conjugate Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Conjugate Vaccines Sales Share by Manufacturers
Figure 2016 Conjugate Vaccines Sales Share by Manufacturers
Table Global Conjugate Vaccines Revenue by Manufacturers (2015 and 2016)
Table Global Conjugate Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Conjugate Vaccines Revenue Share by Manufacturers
Table 2016 Global Conjugate Vaccines Revenue Share by Manufacturers
Table Manufacturers Conjugate Vaccines Manufacturing Base Distribution and Product Type
Table Global Conjugate Vaccines Sales Market by Region (2011-2021)
Figure Global Conjugate Vaccines Sales Market by Region (2011-2021)
Figure Global Conjugate Vaccines Sales Market Share by Region (2011-2021)
Table Global Conjugate Vaccines Revenue Market by Region (2011-2021)
Table Global Conjugate Vaccines Revenue Market Share by Region (2011-2021)
Table North America Conjugate Vaccines Sales, Revenue and Price (2011-2021)
Figure North America Conjugate Vaccines Sales, Revenue and Growth Rate (2011-2021)
Table Europe Conjugate Vaccines Sales, Revenue and Price (2011-2021)
Figure Europe Conjugate Vaccines Sales, Revenue and Growth Rate (2011-2021)
Table China Conjugate Vaccines Sales, Revenue and Price (2011-2021)
Figure China Conjugate Vaccines Sales, Revenue and Growth Rate (2011-2021)
Table Japan Conjugate Vaccines Sales, Revenue and Price (2011-2021)
Figure Japan Conjugate Vaccines Sales, Revenue and Growth Rate (2011-2021)
Table India Conjugate Vaccines Sales, Revenue and Price (2011-2021)
Figure India Conjugate Vaccines Sales, Revenue and Growth Rate (2011-2021)
Table Southeast Asia Conjugate Vaccines Sales, Revenue and Price (2011-2021)
Figure Southeast Asia Conjugate Vaccines Sales, Revenue and Growth Rate  (2011-2021)
Table Global Conjugate Vaccines Sales by Type (2011-2021)
Table Global Conjugate Vaccines Sales Share by Type (2011-2021)
Figure Sales Market Share of Conjugate Vaccines by Type (2011-2021)
Figure Global Conjugate Vaccines Sales Growth Rate by Type (2011-2021)
Table Global Conjugate Vaccines Revenue by Type (2011-2021)
Table Global Conjugate Vaccines Revenue Share by Type (2011-2021)
Figure Global Conjugate Vaccines Revenue Growth Rate by Type (2011-2021)
Figure Pneumococcal Sales, Revenue and Growth (2011-2021)
Figure Pneumococcal Price Trend (2011-2021)
Figure Influenza Sales, Revenue and Growth (2011-2021)
Figure Influenza Price Trend (2011-2021)
Figure HPV Sales, Revenue and Growth (2011-2021)
Figure HPV Price Trend (2011-2021)
Figure Hepatitis Sales, Revenue and Growth (2011-2021)
Figure Hepatitis Price Trend (2011-2021)
Figure Rotavirus Sales, Revenue and Growth (2011-2021)
Figure Rotavirus Price Trend (2011-2021)
Figure DTP Sales, Revenue and Growth (2011-2021)
Figure DTP Price Trend (2011-2021)
Figure Polio Sales, Revenue and Growth (2011-2021)
Figure Polio Price Trend (2011-2021)
Figure MMR Sales, Revenue and Growth (2011-2021)
Figure MMR Price Trend (2011-2021)
Table Global Conjugate Vaccines Sales by Application (2011-2021)
Table Global Conjugate Vaccines Sales Market Share by Application (2011-2021)
Figure Global Conjugate Vaccines Sales Market Share by Application in 2015
Figure Global Conjugate Vaccines Sales Market Share by Application in 2021
Table North America Conjugate Vaccines Sales by Application (2015 and 2016)
Table Europe Conjugate Vaccines Sales by Application (2015 and 2016)
Table China Conjugate Vaccines Sales by Application (2015 and 2016)
Table Japan Conjugate Vaccines Sales by Application (2015 and 2016)
Table India Conjugate Vaccines Sales by Application (2015 and 2016)
Table Southeast Asia Conjugate Vaccines Sales by Application (2015 and 2016)
Table Global Conjugate Vaccines Sales Growth Rate by Application (2011-2021)
Figure Global Conjugate Vaccines Sales Growth Rate by Application (2011-2021)
Table Astellas Pharma Inc Basic Information List
Table Conjugate Vaccines Sales, Revenue, Price of Astellas Pharma Inc (2015 and 2016)
Table CSL Limited Basic Information List
Table Conjugate Vaccines Sales, Revenue, Price of CSL Limited (2015 and 2016)
Table Emergent BioSolutions, Inc Basic Information List
Table Conjugate Vaccines Sales, Revenue, Price of Emergent BioSolutions, Inc (2015 and 2016)
Table GlaxoSmithKline Basic Information List
Table Conjugate Vaccines Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
Table Johnson & Johnson Basic Information List
Table Conjugate Vaccines Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
Table MedImmune, LLC Basic Information List
Table Conjugate Vaccines Sales, Revenue, Price of MedImmune, LLC (2015 and 2016)
Table Merck & Co Basic Information List
Table Conjugate Vaccines Sales, Revenue, Price of Merck & Co (2015 and 2016)
Table Pfizer Basic Information List
Table Conjugate Vaccines Sales, Revenue, Price of Pfizer (2015 and 2016)
Table Sanofi Pasteur Basic Information List
Table Conjugate Vaccines Sales, Revenue, Price of Sanofi Pasteur (2015 and 2016)
Table Serum Institute Basic Information List
Table Conjugate Vaccines Sales, Revenue, Price of Serum Institute (2015 and 2016)
Table India Pvt. Ltd. (India) Basic Information List
Table Conjugate Vaccines Sales, Revenue, Price of India Pvt. Ltd. (India) (2015 and 2016)
 



To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $2900
Multi User - US $3770
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify